Come up with a name for your new list and we'll add to it:
Avid Radiopharmaceuticals was acquired by
Eli Lilly & Co. on November 08, 2010.
Avid is a clinical-stage product-focused molecular imaging company with IP in the field of molecular brain imaging. Per the company, Avid has developed targeting agents to image amyloid plaques and a…